BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Insel PA, Sriram K, Gorr MW, Wiley SZ, Michkov A, Salmerón C, Chinn AM. GPCRomics: An Approach to Discover GPCR Drug Targets. Trends Pharmacol Sci 2019;40:378-87. [PMID: 31078319 DOI: 10.1016/j.tips.2019.04.001] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 13.7] [Reference Citation Analysis]
Number Citing Articles
1 Von Moo E, Harpsøe K, Hauser AS, Masuho I, Bräuner-Osborne H, Gloriam DE, Martemyanov KA. Ligand-directed bias of G protein signaling at the dopamine D2 receptor. Cell Chem Biol 2021:S2451-9456(21)00314-7. [PMID: 34302750 DOI: 10.1016/j.chembiol.2021.07.004] [Reference Citation Analysis]
2 Zhao F, Wu Y, Zhou F, Xue D, Zhao S, Lu W, Liu X, Hu T, Qiu Y, Li R, Gu T, Xu Y, Xu F, Zhong G, Jiang Z, Zhao S, Tao H. Elucidation of Distinct Modular Assemblies of Smoothened Receptor by Bitopic Ligand Measurement. J Med Chem 2021;64:13830-40. [PMID: 34492176 DOI: 10.1021/acs.jmedchem.1c01220] [Reference Citation Analysis]
3 Sarkar P, Rao BD, Chattopadhyay A. Cell Cycle Dependent Modulation of Membrane Dipole Potential and Neurotransmitter Receptor Activity: Role of Membrane Cholesterol. ACS Chem Neurosci 2020;11:2890-9. [PMID: 32786305 DOI: 10.1021/acschemneuro.0c00499] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Höfurthner T, Mateos B, Konrat R. On-Cell NMR Contributions to Membrane Receptor Binding Characterization. Chempluschem 2021;86:938-45. [PMID: 34160899 DOI: 10.1002/cplu.202100134] [Reference Citation Analysis]
5 Sarkar P, Jafurulla M, Bhowmick S, Chattopadhyay A. Structural Stringency and Optimal Nature of Cholesterol Requirement in the Function of the Serotonin1A Receptor. J Membrane Biol 2020;253:445-57. [DOI: 10.1007/s00232-020-00138-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
6 Ma X, Leurs R, Vischer HF. NanoLuc-Based Methods to Measure β-Arrestin2 Recruitment to G Protein-Coupled Receptors. Methods Mol Biol 2021;2268:233-48. [PMID: 34085273 DOI: 10.1007/978-1-0716-1221-7_16] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Schmidt M, Cattani-Cavalieri I, Nuñez FJ, Ostrom RS. Phosphodiesterase isoforms and cAMP compartments in the development of new therapies for obstructive pulmonary diseases. Curr Opin Pharmacol 2020;51:34-42. [PMID: 32622335 DOI: 10.1016/j.coph.2020.05.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
8 Chinn AM, Insel PA. Cyclic AMP in dendritic cells: A novel potential target for disease-modifying agents in asthma and other allergic disorders. Br J Pharmacol 2020;177:3363-77. [PMID: 32372523 DOI: 10.1111/bph.15095] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Kowluru A. GPCRs, G Proteins, and Their Impact on β-cell Function. Compr Physiol 2020;10:453-90. [PMID: 32163203 DOI: 10.1002/cphy.c190028] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
10 Sutkeviciute I, Lee JY, White AD, Maria CS, Peña KA, Savransky S, Doruker P, Li H, Lei S, Kaynak B, Tu C, Clark LJ, Sanker S, Gardella TJ, Chang W, Bahar I, Vilardaga JP. Precise druggability of the PTH type 1 receptor. Nat Chem Biol 2021. [PMID: 34949836 DOI: 10.1038/s41589-021-00929-w] [Reference Citation Analysis]
11 Laasfeld T, Ehrminger R, Tahk MJ, Veiksina S, Kõlvart KR, Min M, Kopanchuk S, Rinken A. Budded baculoviruses as a receptor display system to quantify ligand binding with TIRF microscopy. Nanoscale 2021;13:2436-47. [PMID: 33464268 DOI: 10.1039/d0nr06737g] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
12 Jabeen A, Vijayram R, Ranganathan S. BIO-GATS: A Tool for Automated GPCR Template Selection Through a Biophysical Approach for Homology Modeling. Front Mol Biosci 2021;8:617176. [PMID: 33898512 DOI: 10.3389/fmolb.2021.617176] [Reference Citation Analysis]
13 Kumar A, Sarkar P, Chattopadhyay A. Metabolic Depletion of Sphingolipids Reduces Cell Surface Population of the Human Serotonin1A Receptor due to Impaired Trafficking. ACS Chem Neurosci 2021;12:1189-96. [PMID: 33760584 DOI: 10.1021/acschemneuro.1c00017] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Liu S, Kang WJ, Abrimian A, Xu J, Cartegni L, Majumdar S, Hesketh P, Bekker A, Pan YX. Alternative Pre-mRNA Splicing of the Mu Opioid Receptor Gene, OPRM1: Insight into Complex Mu Opioid Actions. Biomolecules 2021;11:1525. [PMID: 34680158 DOI: 10.3390/biom11101525] [Reference Citation Analysis]
15 Fatakia SN, Sarkar P, Chattopadhyay A. Molecular evolution of a collage of cholesterol interaction motifs in transmembrane helix V of the serotonin1A receptor. Chem Phys Lipids 2020;232:104955. [PMID: 32846149 DOI: 10.1016/j.chemphyslip.2020.104955] [Reference Citation Analysis]
16 Han B, Zhang YY, Ye ZQ, Xiao Y, Rasouli J, Wu WC, Ye SM, Guo XY, Zhu L, Rostami A, Wang LB, Zhang Y, Li X. Montelukast alleviates inflammation in experimental autoimmune encephalomyelitis by altering Th17 differentiation in a mouse model. Immunology 2021;163:185-200. [PMID: 33480040 DOI: 10.1111/imm.13308] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Marchetti L, Porciani D, Mitola S, Giacomelli C. Editorial: Molecular Insights Into Ligand-Receptor Interactions on the Cell Surface. Front Mol Biosci 2022;9:921677. [DOI: 10.3389/fmolb.2022.921677] [Reference Citation Analysis]
18 Brandum EP, Jørgensen AS, Rosenkilde MM, Hjortø GM. Dendritic Cells and CCR7 Expression: An Important Factor for Autoimmune Diseases, Chronic Inflammation, and Cancer. Int J Mol Sci 2021;22:8340. [PMID: 34361107 DOI: 10.3390/ijms22158340] [Reference Citation Analysis]
19 Overduin M, Trieber C, Prosser RS, Picard LP, Sheff JG. Structures and Dynamics of Native-State Transmembrane Protein Targets and Bound Lipids. Membranes (Basel) 2021;11:451. [PMID: 34204456 DOI: 10.3390/membranes11060451] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Blaho VA. Druggable Sphingolipid Pathways: Experimental Models and Clinical Opportunities. Adv Exp Med Biol 2020;1274:101-35. [PMID: 32894509 DOI: 10.1007/978-3-030-50621-6_6] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Insel PA, Sriram K, Salmerón C, Wiley SZ. Proton-sensing G protein-coupled receptors: detectors of tumor acidosis and candidate drug targets. Future Med Chem 2020;12:523-32. [PMID: 32116003 DOI: 10.4155/fmc-2019-0357] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
22 Suteau V, Seegers V, Munier M, Ben Boubaker R, Reyes C, Gentien D, Wery M, Croué A, Illouz F, Hamy A, Rodien P, Briet C. G Protein-coupled Receptors in Radioiodine-refractory Thyroid Cancer in the Era of Precision Medicine. J Clin Endocrinol Metab 2021;106:2221-32. [PMID: 34000025 DOI: 10.1210/clinem/dgab343] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Sarkar P, Chattopadhyay A. Cholesterol in GPCR Structures: Prevalence and Relevance. J Membr Biol 2021. [PMID: 34365520 DOI: 10.1007/s00232-021-00197-8] [Reference Citation Analysis]
24 Li M, Wang X, Ma RR, Shi DB, Wang YW, Li XM, He JY, Wang J, Gao P. The Olfactory Receptor Family 2, Subfamily T, Member 6 (OR2T6) Is Involved in Breast Cancer Progression via Initiating Epithelial-Mesenchymal Transition and MAPK/ERK Pathway. Front Oncol 2019;9:1210. [PMID: 31781505 DOI: 10.3389/fonc.2019.01210] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
25 Luyao H, Luesch H, Uy M. GPCR Pharmacological Profiling of Aaptamine from the Philippine Sponge Stylissa sp. Extends Its Therapeutic Potential for Noncommunicable Diseases. Molecules 2021;26:5618. [PMID: 34577088 DOI: 10.3390/molecules26185618] [Reference Citation Analysis]
26 Sharma P, Penn RB. Can GPCRs Be Targeted to Control Inflammation in Asthma? Adv Exp Med Biol 2021;1304:1-20. [PMID: 34019260 DOI: 10.1007/978-3-030-68748-9_1] [Reference Citation Analysis]
27 Ortega JT, Jastrzebska B. The Retinoid and Non-Retinoid Ligands of the Rod Visual G Protein-Coupled Receptor. Int J Mol Sci 2019;20:E6218. [PMID: 31835521 DOI: 10.3390/ijms20246218] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
28 Gad AA, Balenga N. The Emerging Role of Adhesion GPCRs in Cancer. ACS Pharmacol Transl Sci 2020;3:29-42. [PMID: 32259086 DOI: 10.1021/acsptsci.9b00093] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
29 Han M, Zhang M. The regulatory mechanism of amino acids on milk protein and fat synthesis in mammary epithelial cells: a mini review. Anim Biotechnol 2021;:1-11. [PMID: 34339350 DOI: 10.1080/10495398.2021.1950743] [Reference Citation Analysis]
30 Pal S, Chattopadhyay A. Extramembranous Regions in G Protein-Coupled Receptors: Cinderella in Receptor Biology? J Membrane Biol 2019;252:483-97. [DOI: 10.1007/s00232-019-00092-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
31 Raines R, Mcknight I, White H, Legg K, Lee C, Li W, Lee PHU, Shim JW. Drug-Targeted Genomes: Mutability of Ion Channels and GPCRs. Biomedicines 2022;10:594. [DOI: 10.3390/biomedicines10030594] [Reference Citation Analysis]
32 Vaganova AN, Kuvarzin SR, Sycheva AM, Gainetdinov RR. Deregulation of Trace Amine-Associated Receptors (TAAR) Expression and Signaling Mode in Melanoma. Biomolecules 2022;12:114. [DOI: 10.3390/biom12010114] [Reference Citation Analysis]
33 Hong W, Yang B, He Q, Wang J, Weng Q. New Insights of CCR7 Signaling in Dendritic Cell Migration and Inflammatory Diseases. Front Pharmacol 2022;13:841687. [DOI: 10.3389/fphar.2022.841687] [Reference Citation Analysis]
34 Shrivastava S, Sarkar P, Preira P, Salomé L, Chattopadhyay A. Role of Actin Cytoskeleton in Dynamics and Function of the Serotonin1A Receptor. Biophys J 2020;118:944-56. [PMID: 31606121 DOI: 10.1016/j.bpj.2019.08.034] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
35 Poll BG, Chen L, Chou CL, Raghuram V, Knepper MA. Landscape of GPCR expression along the mouse nephron. Am J Physiol Renal Physiol 2021;321:F50-68. [PMID: 34029142 DOI: 10.1152/ajprenal.00077.2021] [Reference Citation Analysis]
36 Yang D, Zhou Q, Labroska V, Qin S, Darbalaei S, Wu Y, Yuliantie E, Xie L, Tao H, Cheng J, Liu Q, Zhao S, Shui W, Jiang Y, Wang MW. G protein-coupled receptors: structure- and function-based drug discovery. Signal Transduct Target Ther 2021;6:7. [PMID: 33414387 DOI: 10.1038/s41392-020-00435-w] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
37 El-Behery H, Attia AF, El-Feshawy N, Torkey H. Efficient machine learning model for predicting drug-target interactions with case study for Covid-19. Comput Biol Chem 2021;93:107536. [PMID: 34271420 DOI: 10.1016/j.compbiolchem.2021.107536] [Reference Citation Analysis]
38 Dutta A, Sarkar P, Shrivastava S, Chattopadhyay A. Effect of Hypoxia on the Function of the Human Serotonin1A Receptor. ACS Chem Neurosci 2022. [PMID: 35467841 DOI: 10.1021/acschemneuro.2c00181] [Reference Citation Analysis]
39 Kroning KE, Wang W. Temporally gated molecular tools for tracking protein-protein interactions in live cells. Methods Enzymol 2020;640:205-23. [PMID: 32560799 DOI: 10.1016/bs.mie.2020.04.029] [Reference Citation Analysis]
40 Dutka P, Mukherjee S, Gao X, Kang Y, de Waal PW, Wang L, Zhuang Y, Melcher K, Zhang C, Xu HE, Kossiakoff AA. Development of "Plug and Play" Fiducial Marks for Structural Studies of GPCR Signaling Complexes by Single-Particle Cryo-EM. Structure 2019;27:1862-1874.e7. [PMID: 31669042 DOI: 10.1016/j.str.2019.10.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
41 Monfared RV, Alhassen W, Truong TM, Gonzales MAM, Vachirakorntong V, Chen S, Baldi P, Civelli O, Alachkar A. Transcriptome Profiling of Dysregulated GPCRs Reveals Overlapping Patterns across Psychiatric Disorders and Age-Disease Interactions. Cells 2021;10:2967. [PMID: 34831190 DOI: 10.3390/cells10112967] [Reference Citation Analysis]
42 Gorr MW, Sriram K, Muthusamy A, Insel PA. Transcriptomic analysis of pulmonary artery smooth muscle cells identifies new potential therapeutic targets for idiopathic pulmonary arterial hypertension. Br J Pharmacol 2020;177:3505-18. [PMID: 32337710 DOI: 10.1111/bph.15074] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
43 Patel BS, Ravix J, Pabelick C, Prakash YS. Class C GPCRs in the airway. Curr Opin Pharmacol 2020;51:19-28. [PMID: 32375079 DOI: 10.1016/j.coph.2020.04.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
44 Kinsella GK, Cannito S, Bordano V, Stephens JC, Rosa AC, Miglio G, Guaschino V, Iannaccone V, Findlay JBC, Benetti E. GPR21 Inhibition Increases Glucose-Uptake in HepG2 Cells. Int J Mol Sci 2021;22:10784. [PMID: 34639123 DOI: 10.3390/ijms221910784] [Reference Citation Analysis]
45 Haak AJ, Ducharme MT, Diaz Espinosa AM, Tschumperlin DJ. Targeting GPCR Signaling for Idiopathic Pulmonary Fibrosis Therapies. Trends Pharmacol Sci 2020;41:172-82. [PMID: 32008852 DOI: 10.1016/j.tips.2019.12.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]